{
    "clinical_study": {
        "@rank": "105866", 
        "acronym": "SUPPORT", 
        "arm_group": [
            {
                "arm_group_label": "Active group", 
                "arm_group_type": "Experimental", 
                "description": "The software application used on the patients' smart phones in the active group, will contain both the e-diary and the mobile-phone based patient support. Patients will receive feedback by the mobile-phone based support not only on the data they enter into the mobile-phone based patient support but also on their reported daily ticagrelor use."
            }, 
            {
                "arm_group_label": "The control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "In this group the patients will have access to the e-diary only, in which they will report their daily use of ticagrelor. The patients in the control group will not receive any feed-back."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate whether the mobile-phone based patient support has\n      an impact on the adherence and persistence of ticagrelor treatment or on lifestyle changes\n      that will have a positive impact on the cardiovascular  risk factors."
        }, 
        "brief_title": "A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Provision of written patient informed consent.\n\n          2. Patients must have a smart phone at their disposal and use it on a daily basis.\n\n          3. Female or male aged >18 years, diagnosed with a ST elevation Myocardial Infarction\n             (STEMI) or non ST elevation Myocardial Infarction (NSTEMI) and treated with\n             ticagrelor prior to inclusion into this study and for which the treating physician\n             intend to continue prescribing ticagrelor according to the prescription\n             recommendation.\n\n          4. Ability to read, understand and write Swedish.\n\n        Exclusion Criteria:\n\n          1. Participation in any clinical trial or device study in the last 30 days excluding\n             prospective/retrospective register based studies that do not require any extra visits\n             in addition to ordinary health care.\n\n          2. Patients not suitable for participation based on the investigators judgment for\n             example:\n\n               -  Patients on treatment with triple antithrombotic treatment.\n\n               -  Patients on treatment with anticoagulantia.\n\n               -  Patients accepted/with a plan for thoracic surgery (CABG) or any other elective\n                  surgery that cannot be postponed until after study participation.\n\n               -  Patients with a life expectancy of less than 12 months.\n\n               -  Patients judged to be unable to follow a structured physical activity program.\n\n          3. Patients those are pregnant or lactating.\n\n          4. Patients involved in the planning and/or conduct of the study (applies to AstraZeneca\n             staff and/or staff at the study site and application developer)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01874262", 
            "org_study_id": "ME-CV-1301"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active group", 
                "description": "The mobile-phone based patient support (investigational medical device) is a stand-alone software product used on the patients' own smart phone and used in addition to medical treatment.", 
                "intervention_name": "Mobile-phone based patient support", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Active group", 
                    "The control group"
                ], 
                "description": "All patients (active and control group) participating in the study will report their daily use of ticagrelor in an e-diary which will be initiated on all study patients' smart phones.", 
                "intervention_name": "e-diary", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "G\u00f6teborg", 
                        "country": "Sweden", 
                        "zip": "413 45"
                    }, 
                    "name": "Kardiologi Dagv\u00e5rd, Gr\u00f6na str\u00e5ket 2, Sahlgrenska Universitetssjukhuset"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "J\u00f6nk\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "551 85"
                    }, 
                    "name": "Medicinkliniken, Hj\u00e4rtsektionen, L\u00e4nssjukhuset Ryhov"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "73181"
                    }, 
                    "name": "Medicinkliniken K\u00f6ping, V\u00e4stmanlands sjukhus K\u00f6ping"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "581 85"
                    }, 
                    "name": "Kardiologiska kliniken, Hj\u00e4rtcentrum, Universitetssjukhuset Link\u00f6ping"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nyk\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "611 85"
                    }, 
                    "name": "Medicinkliniken Nyk\u00f6pings Lasarett"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "112 81"
                    }, 
                    "name": "Hj\u00e4rtmottagningen Capio S:t G\u00f6rans sjukhus"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "171 76"
                    }, 
                    "name": "Hj\u00e4rtkliniken, Karolinska Universitetssjukhuset, Solna"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "182 88"
                    }, 
                    "name": "Hj\u00e4rtkliniken, Danderyds Sjukhus AB"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sundsvall", 
                        "country": "Sweden", 
                        "zip": "851 86"
                    }, 
                    "name": "Kardiologisektionen Medicinkliniken, L\u00e4nssjukhuset Sundsvall"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ume\u00e5", 
                        "country": "Sweden", 
                        "zip": "901 85"
                    }, 
                    "name": "Hj\u00e4rtmottagningen, Hj\u00e4rtcentrum, Norrlands Universitetssjukhus"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Uppsala", 
                        "country": "Sweden", 
                        "zip": "751 85"
                    }, 
                    "name": "Kardiologkliniken, Akademiska Sjukhuset"
                }, 
                "investigator": {
                    "last_name": "Christoph Varenhorst Varenhorst", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varberg", 
                        "country": "Sweden", 
                        "zip": "43281"
                    }, 
                    "name": "Medicinkliniken, Hallands sjukhus Varberg"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "V\u00e4ster\u00e5s", 
                        "country": "Sweden", 
                        "zip": "721 89"
                    }, 
                    "name": "Hj\u00e4rtsektionen, Medicinkliniken, V\u00e4stmanlands Sjukhus V\u00e4ster\u00e5s"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "V\u00e4xj\u00f6", 
                        "country": "Sweden", 
                        "zip": "351 85"
                    }, 
                    "name": "Hj\u00e4rtmottagningen CLV, Medicinkliniken, Centrallasarettet V\u00e4xsj\u00f6"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u00d6rebro", 
                        "country": "Sweden", 
                        "zip": "701 85"
                    }, 
                    "name": "Kardiologiska kliniken, Universitetssjukhuset \u00d6rebro"
                }, 
                "investigator": {
                    "last_name": "Thomas Kellerth", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction - SUPPORT", 
        "overall_contact": {
            "email": "susanna.pozarek@astrazeneca.com", 
            "last_name": "Susanna Pozarek"
        }, 
        "overall_official": {
            "affiliation": "Kardiologkliniken, Akademiska Sjukhuset Uppsala", 
            "last_name": "Christoph Varenhorst, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Sweden: Regional Ethical Review Board", 
                "Sweden: Medical Products Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome will be a composite endpoint consisting of adherence failure events and treatment gaps:\nAdherence failure events are defined as more than 14% missed doses during an observation cycle of 7 days. The first missed dose of ticagrelor initiates an observation cycle of 1 week. If a second missed dose is registered within this week an adherence failure event is registered. The third missed dose initiates a new observation cycle, and the process restarts.\nTreatment gaps are defined as patient reported gaps of more than 4 consecutive doses during the participation in the study.", 
            "measure": "Adherence", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01874262"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}